Skip to content

Clinical trials

Phase 2 Endometrial Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 2 Country / region: China Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20201
20215
20224
20235
20246
202510
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting17
Not yet recruiting11
Unknown status5
Completed3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University People's Hospital5
Fudan University4
Sun Yat-sen University3
Peking Union Medical College Hospital2
3D Medicines (Sichuan) Co., Ltd.1
Akeso1
AstraZeneca1
Bayer1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms37
Uterine Cervical Neoplasms10
Ovarian Neoplasms8
Breast Neoplasms5
Endometrial Hyperplasia5
Stomach Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Colorectal Neoplasms3
Lung Neoplasms3
Neoplasm Metastasis3

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.